Lv7
4906 积分 2021-05-26 加入
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment
1天前
已完结
A general perspective for the conduct of radiolabelled distribution, metabolism, and excretion studies for antibody-drug conjugates
15天前
已完结
Dual-target EZH2 inhibitor: latest advances in medicinal chemistry
2个月前
已完结
Industry Perspective on the Pharmacokinetic and Absorption, Distribution, Metabolism, and Excretion Characterization of Heterobifunctional Protein Degraders
3个月前
已完结
Metabolism of New Drug Modalities Research Advances – 2024 year in review
3个月前
已完结
Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling
4个月前
已完结
Discovery of novel benzbromarone derivatives via the closed metabolic site as potent human uric acid transporter 1 (URAT1) inhibitors
4个月前
已完结
Discovery of novel benzbromarone derivatives via the closed metabolic site as potent human uric acid transporter 1 (URAT1) inhibitors
5个月前
已完结
Finding a needle in the haystack: ADME and pharmacokinetics/pharmacodynamics characterization and optimization toward orally available bifunctional protein degraders
5个月前
已完结
皖公网安备34019202002308
